The Department of Health is offering a grant to support the VMMC program expansion in South Africa under PEPFAR. The grant aims to increase male circumcision coverage among males aged 15-49 years to prevent new HIV infections and reduce HIV care costs. The program also provides health education, counseling, and HIV testing services. Additionally, VMMC indirectly reduces women’s risk of HIV infection and sexually transmitted infections. This grant opportunity aligns with WHO/UNAIDS guidance and the Joint Strategic Action Framework to accelerate VMMC scale-up in regions with generalized HIV epidemics. Closing date for applications is Oct 01, 2016.
Opportunity ID: 286885
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CDC-RFA-GH11-11100501SUPP16 |
| Funding Opportunity Title: | Program Expansion Supplement: Supporting Health Worker Staffing in South Africa under PEPFAR |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.067 — Global AIDS |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Aug 02, 2016 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Oct 01, 2016 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Current Closing Date for Applications: | Oct 01, 2016 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Archive Date: | Oct 31, 2016 |
| Estimated Total Program Funding: | $1,360,545 |
| Award Ceiling: | $1,360,545 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Eligible applicants that can apply for this funding opportunity are listed below: The Aurum Institute |
Additional Information
| Agency Name: | Centers for Disease Control – CGH |
| Description: | VMMC is a one-time procedure that reduces men’s risk of acquiring HIV from heterosexual exposure for a lifetime. Three randomized controlled trials (RCT) demonstrated that VMMC reduces men’s risk of HIV acquisition by approximately 60%, making it one of the most effective HIV prevention interventions known. Extended follow-up of participants in the Uganda and Kenya RCTs through five and six years post-trial indicated that the protective effect was sustained or increased at 67-73% and 58%, respectively (Gray, 2012) (Mehta, 2013). WHO/UNAIDS issued normative guidance in March 2007, recognizing that VMMC is an additional important intervention to reduce the risk of male heterosexually acquired HIV infection, (World Health Organization, 2007) and subsequently issued the Joint Strategic Action Framework to Accelerate the Scale-Up of Voluntary Medical Male Circumcision for HIV Prevention in Eastern and Southern African countries with generalized HIV epidemics where male circumcision is uncommon. A target was set to reach 80% circumcision coverage among males aged 15-49 years in 14 these priority countries in the region, equivalent to 20.3 million VMMCs, by the end of 2016 (Joint United Nations Programme on HIV/AIDS, 2007). Mathematical modeling suggests that if 8 out of 10 adult men will become circumcised within 5 years, approximately 3.4 million new HIV infections may be prevented in 15 years, saving as much as $16.5 billion in HIV care and treatment costs (Njeuhmeli, 2011). In South Africa, one case of HIV may be prevented for every 5 men who become circumcised in this scenario. VMMC programs also offer unprecedented opportunities to engage men in health education and counseling, notably HIV testing and counseling services which is recommended and provided in all PEPFAR VMMC programs. Furthermore, men who are identified as HIV positive by VMMC programs are referred for HIV care and treatment, broadening the potential community-level HIV prevention benefits of the program, as HIV-infected persons on treatment are much less likely to transmit HIV to their sexual partners (Cohen MS et al, 2011). VMMC also has a large, even though indirect, effect on women’s risk of HIV infection. As HIV prevalence decreases in men as a result of becoming circumcised, women’s probabilities of encountering HIV-infected partners are also reduced. In fact, almost half of the new HIV infections that may be prevented are among women, if scale-up is rapid, as described in the above modeling scenario. Women with circumcised male sex partners also have reduced risk of sexually transmitted infections, including carcinogenic strains of HPV, and associated cervical cancer (Pintye, 2014) (Wawer M. e., 2011) (Casteluega, 2002). |
| Link to Additional Information: | |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Priyanka Rathod
wnv9@cdc.gov Email:wnv9@cdc.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 286885 Full Announcement-Full Announcement -> S Africa CDC-RFA-GH11-11100501SUPP16.pdf
Packages
| Agency Contact Information: | Priyanka Rathod wnv9@cdc.gov Email: wnv9@cdc.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.067 | CDC-RFA-GH11-11100501SUPP16 | Program Expansion Supplement: Supporting Health Worker Staffing in South Africa under PEPFAR | PKG00226334 | Aug 02, 2016 | Oct 01, 2016 | View |
Package 1
Mandatory forms
286885 SF424_2_1-2.1.pdf
286885 SF424A-1.0.pdf
286885 BudgetNarrativeAttachments_1_2-1.2.pdf
286885 ProjectNarrativeAttachments_1_2-1.2.pdf
286885 SF424D-1.1.pdf
286885 SF424B-1.1.pdf
Optional forms
286885 OtherNarrativeAttachments_1_2-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
